logo
Plus   Neg
Share
Email

Alnylam Pharmaceuticals Inc. Q1 adjusted earnings Beat Estimates

Below are the earnings highlights for Alnylam Pharmaceuticals Inc. (ALNY):

-Earnings: -$182.22 million in Q1 vs. -$181.92 million in the same period last year.
-EPS: -$1.62 in Q1 vs. -$1.73 in the same period last year.
-Excluding items, Alnylam Pharmaceuticals Inc. reported adjusted earnings of -$171.75 million or -$1.52 per share for the period.
-Analysts projected -$1.89 per share
-Revenue: $99.48 million in Q1 vs. $33.29 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT